Description
The Tumor Test Marker YRA385 // YRA391 is an advanced kit designed for precise detection of 18 different tumor markers using chemiluminescence immunoassay (CLIA) analyzers. It is a vital tool in the early detection of cancer, allowing healthcare professionals to identify elevated tumor marker levels in the blood, which can be indicative of various malignant tumors. The test kit is compatible with several tumor markers, including AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA, making it versatile in its application across different cancer types.
Market Price
In the market, the Tumor Test Marker YRA385 // YRA391 is positioned competitively, reflecting its advanced capabilities and certifications such as CE, ISO13485, and FSC. The price range generally varies based on purchase volumes and specific model requirements, from $200 to $500 per box. To obtain an accurate quote tailored to your specific needs, it’s recommended to request a quotation directly from suppliers such as Kalstein Plus.
Frequently Asked Questions
What does the Tumor Test Marker kit detect? The kit is capable of detecting 18 distinct tumor markers, which are instrumental for the diagnosis of different cancers.
Is the kit easy to use? Yes, the kit is designed for seamless integration with CLIA analyzers, ensuring ease of use for laboratory technicians and medical professionals.
How is the product shipped? The kit is available in various package specifications: 50T/BOX, 100T/BOX, and 24T/BOX, and is shipped with rigorous adherence to temperature controls.
Advantages and Disadvantages
Among the advantages of the Tumor Test Marker YRA385 // YRA391 are its comprehensive detection capabilities, high compatibility with multiple analyzers, and certified quality. However, potential disadvantages could include the need for professional operation and initial investment costs associated with high-end laboratory equipment.
Product Use in the Field
In practical settings, this tumor marker test kit is extensively used in hospitals and specialized cancer treatment centers. It aids in regular screening processes and provides critical data for oncologists seeking accurate and timely diagnostic information. This contributes significantly to early cancer detection and subsequent treatment planning.
Recommendations
For optimal use, it is recommended to store the Tumor Test Marker YRA385 // YRA391 kit at a stable temperature between 2-8°C to maintain its efficacy. Regular calibration at 2/6 points as per the guidelines ensures consistent performance. It is also advisable to keep updated on the latest handling procedures and safety standards by participating in training sessions provided by Kalstein Plus.
Features
- Compatible with CLIA analyzers for detecting 18 tumor markers.
- Comes with multi-size packaging for flexible usage.
- Equipped with all necessary certifications for global use.
- Supports early detection strategies in oncology.
Technical Specifications
| Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
| Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
| Analysis Mode | CLIA | ||||||
| Package Specification | 50T/BOX, 100T/BOX, 24T/BOX | ||||||
| Platform | AP(Alkaline Phosphatase) | ||||||
| Storage | 2-8°C | ||||||
| Calibration | 2/6 Points | ||||||
| Certification | CE, ISO13485, FSC | ||||||



